Sleep Apnea and Erectile Dysfunction: Does CPAP Improve ED?

Obstructive sleep apnea (OSA) and erectile dysfunction are associated: a meta-analysis of observational studies found OSA linked to a higher risk of ED (pooled risk ratio 1.82) [4], and another found the odds of ED lower in men without OSA than in men with it [1]. Whether treating OSA with CPAP improves erections is less certain: a meta-analysis found a small improvement in IIEF-5 scores (about 1 point) after CPAP [2], but a Cochrane review judged the evidence very low-certainty [3]. Proposed links include intermittent drops in oxygen, vascular effects and fragmented sleep.

Does Sleep Apnea Cause Erectile Dysfunction? Short Answer

Probably yes, as an association. Meta-analyses of observational studies find that men with OSA have a higher risk of ED [1][4], although these studies cannot prove cause and effect and are heterogeneous. Proposed explanations include repeated drops in blood oxygen that may affect blood vessels, fragmented sleep and stress-hormone activation. OSA is also common alongside obesity, diabetes and cardiovascular disease, which independently cause ED, so a medical evaluation is worthwhile.

How Sleep Apnea Causes ED

• •Testosterone: sleep disruption is thought to lower testosterone in some men with OSA, but we did not review how often or by how much
• •Intermittent hypoxia: repeated oxygen desaturation events damage penile endothelium and reduce NO bioavailability
• •Sympathetic activation: apneic arousal events raise nocturnal cortisol and catecholamines — sustain sympathetic tone that opposes erection
• •Reduced NPT (nocturnal penile tumescence): fragmented REM sleep reduces the erection episodes that occur naturally during normal sleep
• •Oxidative stress: hypoxia-reoxygenation cycles generate reactive oxygen species that damage vascular NO signaling

Recognizing OSA as an ED Cause

• •Snoring history (partner report)
• •Witnessed apneas — partner observes breathing stopping during sleep
• •Excessive daytime sleepiness (Epworth Sleepiness Scale >10)
• •Non-restorative sleep — waking unrefreshed despite adequate hours
• •Nocturia — waking to urinate more than once per night (intrathoracic pressure changes during apnea stimulate atrial natriuretic peptide)
• •Neck circumference >17 inches — anatomical risk factor
• •BMI >30 — obesity strongly predicts OSA

CPAP and ED: What the Evidence Shows

In a meta-analysis of seven studies (206 men with both OSA and ED), IIEF-5 scores improved by about 1 point after CPAP (weighted mean difference 1.14), with high heterogeneity [2]. A Cochrane review of six randomized trials (315 men) was more cautious: the effect of CPAP on ED scores was uncertain, the certainty of the evidence was very low, and the trials were at risk of bias [3]. That review also compared CPAP with sildenafil, which may slightly improve erectile function [3]. Whether adding a PDE5 inhibitor makes sense if CPAP alone is not enough should be decided with your doctor.

Why Untreated OSA Undermines Other ED Treatments

This is a genuinely important, often-missed clinical point: starting a PDE5 inhibitor or TRT without addressing underlying untreated sleep apnea can mean fighting the medication's effect with an ongoing hypoxic and hormonal insult every single night. TRT specifically carries an added wrinkle — testosterone therapy can worsen OSA severity in some men, particularly at higher doses, which creates a frustrating scenario where treating a suspected low-T cause of ED inadvertently worsens the sleep apnea that was contributing to it in the first place. This is exactly why sleep apnea screening deserves to happen before or alongside starting either treatment, not as an afterthought if initial treatment doesn't work as well as expected. A man who starts TRT while undiagnosed OSA continues untreated may see disappointing results and wrongly conclude TRT 'isn't working,' when the real issue is an unaddressed second condition actively working against it.

The Obesity-OSA-ED Triangle

Sleep apnea rarely operates in isolation — it shares a deeply interconnected relationship with obesity and erectile dysfunction that's worth understanding as a triangle rather than three separate problems. Excess weight, particularly around the neck and upper airway, is one of the strongest risk factors for developing OSA in the first place; OSA itself then suppresses testosterone and damages vascular function, both of which independently promote further weight gain (low testosterone favors fat accumulation, and poor sleep disrupts appetite-regulating hormones like leptin and ghrelin); and the resulting weight gain worsens the OSA further, completing a self-reinforcing cycle. This means a man dealing with all three — excess weight, undiagnosed or undertreated OSA, and ED — often can't address any one of them optimally while ignoring the other two. Weight loss alone helps but is harder to achieve with untreated OSA sabotaging both sleep and hormone status; CPAP alone helps but doesn't address an underlying weight-driven anatomical narrowing of the airway; and ED treatment alone (PDE5 inhibitors) helps symptomatically without touching either underlying driver. A comprehensive plan addressing all three simultaneously — sleep study, CPAP or alternative therapy, and a structured weight management plan — tends to produce meaningfully better outcomes than treating any single piece in isolation.

What CPAP Adherence Actually Requires

The erectile function improvements seen in CPAP research depend on consistent, nightly use — and CPAP adherence in the real world is notoriously imperfect, with many patients using it inconsistently or abandoning it within the first year due to mask discomfort, dryness, or simply the adjustment period. If erectile improvement is a specific motivating goal, it's worth knowing upfront that the 3-6 month timeline reported in studies assumes regular use most nights, not occasional or inconsistent use. Working with a sleep specialist on mask fit, humidification settings, and troubleshooting early discomfort in the first few weeks meaningfully improves long-term adherence, which in turn is what determines whether the testosterone and vascular benefits actually materialize.